Skip to main content
Erschienen in: Clinical Pharmacokinetics 1/2007

01.01.2007 | Original Research Article

Clinical Scoring System for the Prediction of Target Site Penetration of Antimicrobials in Patients with Sepsis

verfasst von: Barbara S. Zeitlinger, Markus Zeitlinger, Irmgard Leitner, Markus Müller, Dr Christian Joukhadar

Erschienen in: Clinical Pharmacokinetics | Ausgabe 1/2007

Einloggen, um Zugang zu erhalten

Abstract

Conclusion: The present study investigated the usefulness of routinely employed scoring systems in predicting tissue penetration of antimicrobials. In addition, a novel, easy to use scoring system was designed for the estimation of tissue penetration of antimicrobials in patients with sepsis.
Methods: Tissue pharmacokinetics were assessed in skeletal muscle and subcutaneous adipose tissue by use of the microdialysis technique in 34 patients with sepsis. Tissue penetration of antimicrobials was retrospectively determined by the ratios of the area under the concentration-time curves (AUC) in soft tissues (AUCtissue) to the AUC in plasma (AUCplasma). Mortality and sepsis scores currently used in intensive care were consecutively calculated and correlated with the AUCtissue: AUCplasma ratio. Single laboratory and clinical parameters showing the highest correlation with tissue penetration were identified and used in the novel Tissue Penetration Prediction Score (TPPS).
Results: The currently used scoring systems Simplified Acute Physiology Scores 3 (r = −0.33, p = 0.006), Acute Physiology and Chronic Health Evaluation III (r = −0.27, p = 0.03) and Sepsis-Related (or Sequential) Organ Failure Assessment (r = −0.32, p = 0.01) showed significant overall correlations with tissue penetration. However, their predictive power for the concentrations of antimicrobials in muscle tissue was not satisfying. The parameters oxygen saturation, serum lactate concentration and the dose per time unit of norepinephrine (noradrenaline) administered showed the best correlation with tissue penetration and were used in the TPPS. Its overall correlation (r = −0.52, p = 0.000007) as well as correlations for the concentrations of antimicrobials in muscle (r = −0.46, p = 0.006) and adipose tissue (r = −0.59, p = 0.0003) were better than the currently used scoring systems.
Conclusion: The TPPS may prove to be a powerful tool for the estimation of antimicrobial tissue penetration at the bedside in septic patients. This score may allow for adequate individual dose adjustment in septic patients. However, this needs to be verified in subsequent prospective clinical trials.
Fußnoten
1
The use of trade names is for product identification purposes only and does not imply endorsement.
 
Literatur
1.
Zurück zum Zitat Brun-Buisson C, Meshaka P, Pinton P, et al. EPISEPSIS: a reappraisal of the epidemiology and outcome of severe sepsis in French intensive care units. Intensive Care Med 2004 Apr; 30(4): 580–8PubMedCrossRef Brun-Buisson C, Meshaka P, Pinton P, et al. EPISEPSIS: a reappraisal of the epidemiology and outcome of severe sepsis in French intensive care units. Intensive Care Med 2004 Apr; 30(4): 580–8PubMedCrossRef
2.
Zurück zum Zitat Angus DC, Linde-Zwirble WT, Lidicker J, et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001 Jul; 29(7): 1303–10PubMedCrossRef Angus DC, Linde-Zwirble WT, Lidicker J, et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001 Jul; 29(7): 1303–10PubMedCrossRef
3.
Zurück zum Zitat Ryan DM. Pharmacokinetics of antibiotics in natural and experimental superficial compartments in animals and humans. J Antimicrob Chemother 1993 May; 31 Suppl. D: 1–16PubMedCrossRef Ryan DM. Pharmacokinetics of antibiotics in natural and experimental superficial compartments in animals and humans. J Antimicrob Chemother 1993 May; 31 Suppl. D: 1–16PubMedCrossRef
4.
Zurück zum Zitat Zeitlinger MA, Dehghanyar P, Mayer BX, et al. Relevance of soft-tissue penetration by levofloxacin for target site bacterial killing in patients with sepsis. Antimicrob Agents Chemother 2003 Nov; 47(11): 3548–53PubMedCrossRef Zeitlinger MA, Dehghanyar P, Mayer BX, et al. Relevance of soft-tissue penetration by levofloxacin for target site bacterial killing in patients with sepsis. Antimicrob Agents Chemother 2003 Nov; 47(11): 3548–53PubMedCrossRef
5.
Zurück zum Zitat Baddour LM, Yu VL, Klugman KP, et al. Combination antibiotic therapy lowers mortality among severely ill patients with pneumococcal bacteremia. Am J Respir Crit Care Med 2004 Aug 15; 170(4): 440–4PubMedCrossRef Baddour LM, Yu VL, Klugman KP, et al. Combination antibiotic therapy lowers mortality among severely ill patients with pneumococcal bacteremia. Am J Respir Crit Care Med 2004 Aug 15; 170(4): 440–4PubMedCrossRef
6.
Zurück zum Zitat Garnacho-Montero J, Garcia-Garmendia JL, Barrero-Al-modovar A, et al. Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis. Crit Care Med 2003 Dec; 31(12): 2742–51PubMedCrossRef Garnacho-Montero J, Garcia-Garmendia JL, Barrero-Al-modovar A, et al. Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis. Crit Care Med 2003 Dec; 31(12): 2742–51PubMedCrossRef
7.
Zurück zum Zitat Le Gall JR, Loirat P, Alperovitch A, et al. A simplified acute physiology score for ICU patients. Crit Care Med 1984 Nov; 12(11): 975–7PubMedCrossRef Le Gall JR, Loirat P, Alperovitch A, et al. A simplified acute physiology score for ICU patients. Crit Care Med 1984 Nov; 12(11): 975–7PubMedCrossRef
8.
Zurück zum Zitat Moreno RP, Metnitz PG, Almeida E, et al. SAPS 3: from evaluation of the patient to evaluation of the intensive care unit. Part 2: development of a prognostic model for hospital mortality at ICU admission. Intensive Care Med 2005 Oct; 31(10): 1345–55PubMedCrossRef Moreno RP, Metnitz PG, Almeida E, et al. SAPS 3: from evaluation of the patient to evaluation of the intensive care unit. Part 2: development of a prognostic model for hospital mortality at ICU admission. Intensive Care Med 2005 Oct; 31(10): 1345–55PubMedCrossRef
9.
Zurück zum Zitat Le Gall JR, Lemeshow S, Saulnier F. A new simplified acute physiology score (SAPS II) based on a European/North American multicenter study. JAMA 1993 Dec 22-29; 270(24): 2957–63PubMedCrossRef Le Gall JR, Lemeshow S, Saulnier F. A new simplified acute physiology score (SAPS II) based on a European/North American multicenter study. JAMA 1993 Dec 22-29; 270(24): 2957–63PubMedCrossRef
10.
Zurück zum Zitat Knaus WA, Draper EA, Wagner DP, et al. APACHE II: a severity of disease classification system. Crit Care Med 1985 Oct; 13(10): 818–29PubMedCrossRef Knaus WA, Draper EA, Wagner DP, et al. APACHE II: a severity of disease classification system. Crit Care Med 1985 Oct; 13(10): 818–29PubMedCrossRef
11.
Zurück zum Zitat Knaus WA, Wagner DP, Draper EA, et al. The APACHE III prognostic system: risk prediction of hospital mortality for critically ill hospitalized adults. Chest 1991 Dec; 100(6): 1619–36PubMedCrossRef Knaus WA, Wagner DP, Draper EA, et al. The APACHE III prognostic system: risk prediction of hospital mortality for critically ill hospitalized adults. Chest 1991 Dec; 100(6): 1619–36PubMedCrossRef
12.
Zurück zum Zitat Vincent JL, Moreno R, Takala J, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. Intensive Care Med 1996 Jul; 22(7): 707–10PubMedCrossRef Vincent JL, Moreno R, Takala J, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. Intensive Care Med 1996 Jul; 22(7): 707–10PubMedCrossRef
13.
Zurück zum Zitat Baumgartner JD, Bula C, Vaney C, et al. A novel score for predicting the mortality of septic shock patients. Crit Care Med 1992 Jul; 20(7): 953–60PubMedCrossRef Baumgartner JD, Bula C, Vaney C, et al. A novel score for predicting the mortality of septic shock patients. Crit Care Med 1992 Jul; 20(7): 953–60PubMedCrossRef
14.
Zurück zum Zitat Fry DE. The importance of antibiotic pharmacokinetics in critical illness. Am J Surg 1996 Dec; 172(6A): 20S–5SPubMedCrossRef Fry DE. The importance of antibiotic pharmacokinetics in critical illness. Am J Surg 1996 Dec; 172(6A): 20S–5SPubMedCrossRef
15.
Zurück zum Zitat Muller M, Haag O, Burgdorff T, et al. Characterization of peripheral-compartment kinetics of antibiotics by in vivo microdialysis in humans. Antimicrob Agents Chemother 1996 Dec; 40(12): 2703–9PubMed Muller M, Haag O, Burgdorff T, et al. Characterization of peripheral-compartment kinetics of antibiotics by in vivo microdialysis in humans. Antimicrob Agents Chemother 1996 Dec; 40(12): 2703–9PubMed
16.
Zurück zum Zitat Joukhadar C, Frossard M, Mayer BX, et al. Impaired target site penetration of beta-lactams may account for therapeutic failure in patients with septic shock. Crit Care Med 2001 Feb; 29(2): 385–91PubMedCrossRef Joukhadar C, Frossard M, Mayer BX, et al. Impaired target site penetration of beta-lactams may account for therapeutic failure in patients with septic shock. Crit Care Med 2001 Feb; 29(2): 385–91PubMedCrossRef
17.
Zurück zum Zitat Joukhadar C, Klein N, Dittrich P, et al. Target site penetration of fosfomycin in critically ill patients. J Antimicrob Chemother 2003 May; 51(5): 1247–52PubMedCrossRef Joukhadar C, Klein N, Dittrich P, et al. Target site penetration of fosfomycin in critically ill patients. J Antimicrob Chemother 2003 May; 51(5): 1247–52PubMedCrossRef
18.
Zurück zum Zitat Joukhadar C, Klein N, Mayer BX, et al. Plasma and tissue pharmacokinetics of cefpirome in patients with sepsis. Crit Care Med 2002 Jul; 30(7): 1478–82PubMedCrossRef Joukhadar C, Klein N, Mayer BX, et al. Plasma and tissue pharmacokinetics of cefpirome in patients with sepsis. Crit Care Med 2002 Jul; 30(7): 1478–82PubMedCrossRef
19.
Zurück zum Zitat Bone RC, Sprung CL, Sibbald WJ. Definitions for sepsis and organ failure. Crit Care Med 1992 Jun; 20(6): 724–6PubMedCrossRef Bone RC, Sprung CL, Sibbald WJ. Definitions for sepsis and organ failure. Crit Care Med 1992 Jun; 20(6): 724–6PubMedCrossRef
20.
Zurück zum Zitat Joukhadar C, Derendorf H, Muller M. Microdialysis: a novel tool for clinical studies of anti-infective agents. Eur J Clin Pharmacol 2001 Jun; 57(3): 211–9PubMedCrossRef Joukhadar C, Derendorf H, Muller M. Microdialysis: a novel tool for clinical studies of anti-infective agents. Eur J Clin Pharmacol 2001 Jun; 57(3): 211–9PubMedCrossRef
21.
Zurück zum Zitat Lonnroth P, Jansson PA, Smith U. A microdialysis method allowing characterization of intercellular water space in humans. Am J Physiol 1987 Aug; 253 (2 Pt 1): E228–31PubMed Lonnroth P, Jansson PA, Smith U. A microdialysis method allowing characterization of intercellular water space in humans. Am J Physiol 1987 Aug; 253 (2 Pt 1): E228–31PubMed
22.
Zurück zum Zitat Zeitlinger MA, Erovic BM, Sauermann R, et al. Plasma concentrations might lead to overestimation of target site activity of piperacillin in patients with sepsis. J Antimicrob Chemother 2005 Oct; 56(4): 703–8PubMedCrossRef Zeitlinger MA, Erovic BM, Sauermann R, et al. Plasma concentrations might lead to overestimation of target site activity of piperacillin in patients with sepsis. J Antimicrob Chemother 2005 Oct; 56(4): 703–8PubMedCrossRef
23.
Zurück zum Zitat NCCLS. Document M23-A2: development of in vitro susceptibility testing criteria and quality control parameters: approved guideline. 2nd ed. Wayne (PA): Clinical and Laboratory Standards Institute (CLSI), 2001 NCCLS. Document M23-A2: development of in vitro susceptibility testing criteria and quality control parameters: approved guideline. 2nd ed. Wayne (PA): Clinical and Laboratory Standards Institute (CLSI), 2001
24.
Zurück zum Zitat Levy B, Gibot S, Franck P, et al. Relation between muscle Na+K+ ATPase activity and raised lactate concentrations in septic shock: a prospective study. Lancet 2005 Mar 5–11; 365(9462): 871–5PubMedCrossRef Levy B, Gibot S, Franck P, et al. Relation between muscle Na+K+ ATPase activity and raised lactate concentrations in septic shock: a prospective study. Lancet 2005 Mar 5–11; 365(9462): 871–5PubMedCrossRef
25.
Zurück zum Zitat Luchette F, Jenkins W, Friend L, et al. Hypoxia is not the sole cause of lactate production during shock. J Trauma 2002; 52(3): 415–9PubMedCrossRef Luchette F, Jenkins W, Friend L, et al. Hypoxia is not the sole cause of lactate production during shock. J Trauma 2002; 52(3): 415–9PubMedCrossRef
Metadaten
Titel
Clinical Scoring System for the Prediction of Target Site Penetration of Antimicrobials in Patients with Sepsis
verfasst von
Barbara S. Zeitlinger
Markus Zeitlinger
Irmgard Leitner
Markus Müller
Dr Christian Joukhadar
Publikationsdatum
01.01.2007
Verlag
Springer International Publishing
Erschienen in
Clinical Pharmacokinetics / Ausgabe 1/2007
Print ISSN: 0312-5963
Elektronische ISSN: 1179-1926
DOI
https://doi.org/10.2165/00003088-200746010-00004

Weitere Artikel der Ausgabe 1/2007

Clinical Pharmacokinetics 1/2007 Zur Ausgabe